Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [18F]-florbetaben PET

Autor: Brendel, Matthias, Delker, Andreas, Rötzer, Christina, Böning, Guido, Carlsen, Janette, Cyran, Clemens, Mille, Erik, Gildehaus, Franz Josef, Cumming, Paul, Baumann, Karlheinz, Steiner, Harald, Haass, Christian, Herms, Jochen, Bartenstein, Peter, Rominger, Axel

Publikováno v: In NeuroImage 1 January 2014 84:843-853

Cross-Sectional Comparison of Small Animal [¹⁸F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models.

Autor: Brendel, Matthias, Jaworska, Anna, Grießinger, Eric, Rötzer, Christina, Burgold, Steffen, Gildehaus, Franz-Josef, Carlsen, Janette, Cumming, Paul, Baumann, Karlheinz, Haass, Christian, Steiner, Harald, Bartenstein, Peter, Herms, Jochen, Rominger, Axel

Publikováno v: PLoS ONE; Feb2015, Vol. 10 Issue 2, p1-21, 21p

PET imaging using [18F]florbetaben in Alzheimer's disease mouse models

Autor: Brendel, Matthias, Böning, Guido, Delker, Andreas, Rötzer, Christina, Gildehaus, Franz-Josef, Baumann, Karlheinz, Steiner, Harald, Haass, Christian, Herms, Jochen, Bartenstein, Peter, Rominger, Axel

Publikováno v: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2013 9(4) Supplement:P29-P29

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.

Autor: Brendel M; Dept. of Nuclear Medicine, University of Munich, Munich, Germany., Jaworska A; Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)-site Munich, University of Munich, Munich, Germany; Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology, Warsaw, Poland., Grießinger E; Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)-site Munich, University of Munich, Munich, Germany., Rötzer C; Dept. of Nuclear Medicine, University of Munich, Munich, Germany., Burgold S; Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)-site Munich, University of Munich, Munich, Germany., Gildehaus FJ; Dept. of Nuclear Medicine, University of Munich, Munich, Germany., Carlsen J; Dept. of Nuclear Medicine, University of Munich, Munich, Germany., Cumming P; Department of Nuclear Medicine, University of Erlangen, Erlangen, Germany; Department of Neuroscience and Pharmacology, Copenhagen University, Copenhagen, Denmark., Baumann K; F. Hoffmann-La Roche, Basel, Switzerland., Haass C; Adolf-Butenandt-Institute, Biochemistry, University of Munich, Munich, Germany; DZNE-German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Steiner H; Adolf-Butenandt-Institute, Biochemistry, University of Munich, Munich, Germany; DZNE-German Center for Neurodegenerative Diseases, Munich, Germany., Bartenstein P; Dept. of Nuclear Medicine, University of Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Herms J; Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)-site Munich, University of Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Rominger A; Dept. of Nuclear Medicine, University of Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Publikováno v: PloS one [PLoS One] 2015 Feb 23; Vol. 10 (2), pp. e0116678. Date of Electronic Publication: 2015 Feb 23 (Print Publication: 2015).